Abstract | Contraction and relaxation of the detrusor smooth muscle (DSM), which makes up the wall of the urinary bladder, facilitates the storage and voiding of urine. Several families of K + channels, including voltagegated K + (K V ) channels, Ca 2+
Introduction
The physiological functions of the urinary bladder are to store and periodically release urine, facilitated by the contraction and relaxation of the detrusor smooth muscle (DSM) that comprises the urinary bladder wall. 1 DSM expresses a variety of K + channels that determine DSM excitability and contractility. [1] [2] [3] [4] The fundamental purpose of the DSM K + channels is to precisely regulate and fine-tune Ca 2+ entry via voltage-gated Ca 2+ (Ca V ) channels, and thus the intracellular Ca 2+ concentration that controls DSM contraction and relaxation. Some studies suggest that K + channels expressed in inter stitial cells may also have a role in determining the pattern of DSM spontaneous electrical and contractile activity; however, their particular role in the urinary bladder is less clear compared to in the gut. [5] [6] [7] [8] This Review focuses on the role of K + channels expressed in the DSM cell membrane under normal and pathophysiological conditions, and the function of K + channels at a molecular, single-channel and whole-cell current level, and within isolated DSM tissues, animal models of bladder disease and patients with bladder dysfunction. K + channels are integral membrane proteins that span DSM cell membranes to form a pore that can be penetrated selectively by K + ions. The K + channels are the largest and most diverse group of ion channels, represented by about 80 different genes encoding the pore-forming channel subunits as well as many additional genes encoding regulatory subunits. 9, 10 Several families of K + channels, including voltage-gated K + (K V ) channels, Ca
2+
-activated K + (K Ca ) channels, inwardrectifying ATP-sensitive K + (K ir , K ATP ) channels, and two-pore-domain K + (K 2P ) channels, are expressed and functional in DSM cells ( Figure 1 ). The K + channels have a critical role in maintaining the DSM cell resting membrane potential, illustrated by the negative equilibrium potential for K + . In general, the opening of K + channels causes cell membrane hyperpolarization, limits Ca 2+ entry via L-type Ca V channels and causes DSM relaxation. By contrast, inhibition of DSM K + channels leads to membrane depolarization and activation and opening of L-type Ca V channels, causing DSM contraction. DSM exhibits spontaneous action potentials, 2, 5, [11] [12] [13] [14] [15] [16] which determine the phasic (rhythmic) nature of the spontaneous contractions in this tissue. 5, [16] [17] [18] [19] [20] [21] [22] [23] [24] Ca 2+ entry via L-type Ca V channels is responsible for the initial depolarization phase of the DSM action potential ( Figure 2 ) and leads to an increase in global intracellular Ca 2+ , which activates DSM phasic contractions. 14, 25, 26 The K + channels shape the DSM cell's action potential by delivering repolarization after the initial episode of depolarization. Figure 2 illustrates the specific role of various K + channels in shaping the DSM resting and action potentials, and, subsequently, DSM phasic contractions. The DSM phasic contractions can be abnormally increased under pathophysiological conditions of detrusor overactivity (DO), overactive bladder (OAB), and related urinary incontinence. 1, 2, 24, [27] [28] [29] [30] [31] [32] [33] [34] The importance of K + channels in DSM excitability and contractility suggests that K + channel defects, alterations or mutations, also known as channelopathies, 9 ,10 may cause certain forms of bladder pathologies.
Methods for studying DSM K + channels
The methods for the study of DSM K + channels range from the measurement of K + current flow through a single K + channel to investigation of K + channel function in whole-animal experiments, including the use of animal models of bladder disease as well as genetically engineered mouse models with either altered K + channel structure, or a lack or overexpression of a particular K + channel subtype. In general, most standard molecular and cell biology techniques have been applied to study K + channels in DSM. Currently, an established procedure exists to develop and utilize K + -channel-specific anti bodies for immunocytochemistry and western or northern blot analyses, or to perform reverse transcription PCR (RT-PCR). A recent advancement in DSM K + channel research is the application of a single-cell RT-PCR technique to identify K + channel gene transcripts in single, freshly isolated DSM cells while avoiding contamination with non-DSM cells. 18 has allowed us to study K + channel function and regulation while maintaining the native environment of the DSM cells, thereby preserving the regulatory and signal transduction pathways. 17, 22, 23, 43 The electrophysiological techniques, as well as functional studies on whole animals or isolated DSM strips and whole bladders, can be combined with pharmaco logical approaches when the K + channel is tested by various K + channel inhibitors or activators. The latter are often referred to as 'K + channel openers' . Figure 3 illustrates hypothetical pharmacological dissection of DSM whole-cell K + currents recorded by the perforated patch-clamp technique in response to a voltage-step depolarization similar to the depolarization that occurs during an action potential ( Figure 2 ). Another common technique for studying the role of K + channels uses isometric DSM tension recordings (contractility) of isolated DSM strips in combination with K + channel pharmacological modulators. [16] [17] [18] [22] [23] [24] The ability to genetically manipulate the mouse genome by deleting or overexpressing specific genes encoding K + channel subunits allows us to evaluate the significance of certain K + channel gene products and to study their functional effects from the cellular level to the whole-animal level. The mouse has become the model of choice for genetic engineering, due to its short gesta tion + channel types expressed in detrusor smooth muscle cells. K ir channels (represented by the K ATP channel) have the simplest K + channel structure, with two transmembrane segments (S) connected by a pore loop. Four such subunits form a functional tetrameric channel pore. K 2P channels form a tetrameric pore structure from two subunits each containing two pore loops. K V channel subunits have six transmembrane segments with a voltage sensor in the S4 transmembrane domain. BK channels consist of four pore-forming α-subunits and the four regulatory β1 or β4 subunits. Abbreviations: BK channels, large-conductance voltage-activated and Ca 2+ -activated K + channels; K 2P channels, two-pore-domain K + channels; K ATP channels, inward-rectifying ATP-sensitive K + channels; K ir channels, inward-rectifying K + channels; K V channels, voltage-gated K + channels.
to the K + channel genetic ablation approach, however, is the problem of develop mental compensation, in which protein products of other (usually closely related) genes functionally substitute for a deleted gene, resulting in the absence of obvious phenotypic abnormali ties. For example, genetic deletion of the BK channel (also known as the Maxi-K channel, K Ca 1.1, KCNMA1, or slo) causes protein kinase A (PKA) overexpression to compensate for the channel loss. 17, 44 One interesting transgenic animal model possesses a tetracycline-based genetic switch and can either overexpress or suppress a particular K + channel, the SK3 channel, depending on orally administered doxycycline. 21 The effects of K + channel modulators can also be examined at the wholeorgan level by conducting urodynamic measure ments in animal models of bladder disease.
21,28,45,46
DSM K + channel families
Structurally, all DSM K + channels form a pore-loop and can have a 2, 4, 6, or 7 transmembrane segment (S) architecture ( Figure 1) . Functionally, the K + channels form four major families: K V channels with 6S transmembrane architecture; K Ca channels with 6S or 7S trans membrane architecture; K ir , K ATP channels with 2S transmembrane architecture; and K 2P channel family with 4S trans membrane architecture.
Voltage-gated K + channels Of all the K + channels that control DSM excitability and contractility, the K V channel family is the most diverse, with pronounced variations in their mechanisms of activation and inactivation. In DSM cells, K V channels work to repolarize the membrane potential to end an action potential, and also have a role in setting the resting membrane potential. 13, 25, 36, 37, 47 In the human genome, the K V channel family is represented by 40 genes classified into 12 subfamilies based on their amino acid sequence homology (Table 1) ; each K V gene encodes a pore-forming α-subunit, four of which form a functional K V channel tetramer (Figure 1) . 10, 48, 49 The K V channels use a unique nomenclature in which the number after the K V indicates the gene subfamily (K V 1-K V 12) and the number after the dot indicates the individual K + channel member (K V 1.1, K V 1.2, and so on). Splice variant isoforms are indicated by lowercase letters at the end (K V 1.1a, K V 1.1b, and so on).
48, 49 The Ca 2+ -activated (K Ca 1-K Ca 5), inwardly rectifying (K ir 1-K ir 7), and K 2P (K 2P 1-K 2P 15) channels, described below, use the same classification system.
48
K V 1-K V 4, K V 7, and K V 10-K V 12 form homotetrameric K V channels (Figure 1 ), whereas K V 5, K V 6, K V 8, and K V 9 do not make their own homotetramers but rather form heterotetrameric K V channels with the K V 2 subunits. Splice variance, post-translational modification, and a large variety of accessory K V subunits further diversify the K V channel family. 10 The functional role of K V channels in DSM remains controversial. 13 The reason for this controversy has been the lack of subtype-specific K V channel inhibitors, which has hampered the study of these channels in DSM cells.
All K V channels are inhibited nonselectively by tetraethylammonium (TEA), and most of them by 4-aminopyridine, 10, 12, 25, 47 but these inhibitors do not allow dissection of individual K V channel subtypes. In the past decade, emerging highly specific K V channel inhibitors, most of them toxins isolated from venomous species, have enabled researchers to selectively isolate K V channel subtypes and determine their contribution to complex physiological processes in different tissues (Table 1) . We can now use these same pharmacological tools to identify individual K V channel subtypes and determine their functional role in DSM. One such example is the spider venom peptide stromatoxin 1, which is a highly specific inhibitor of the K V 2.1, K V 2.2 and K V 4.2 homotetramers, as well as K V 2.1/6.3 and K V 2.1/9.3 heterotetramers. 54, 55 This toxin has allowed us to reveal that K V 2 homo tetrameric and hetertetrameric channels contribute to the electrical and contractile activity of rat, guinea pig and human DSM.
18,36,37 Studies from KarlErik Andersson's group showed that retigabine, an activator of K V 7 channels (also known as KCNQ channels), increased micturition volume and voiding intervals and, when given intravesically, decreased capsaicin-induced DO. 46 In rat isolated DSM strips, retigabine reduced both pharmacologically induced and nerve-evoked DSM contractions, effects that were reversed by XE991, a K V 7 channel inhibitor. 56 McCloskey's group also identified K V 7 channels in cells isolated from DSM wall. 8 Data for guinea pig DSM, 26 along with data from our group for rat DSM (G. V. Petkov, unpublished data), show that E4031, a specific inhibitor of the Kv11.1 channel (also known as ERG1, hERG, or KCNH2), increases DSM contractility, indicating a functional role for this K + channel. The role of K V channels in DSM pathophysiology remains largely unexplored. Decreased mRNA expression of the K V 2.1 channel in a rat model of DSM hyper-reflexia induced by spinal cord injury has been reported, 53 but this study lacked sufficient quantitative evaluation to support such a finding.
The structural diversity of the K V channels contributes to the variety of their pharmacological properties and makes them potentially attractive targets for pharmacological treatment in bladder diseases.
18,27,50 However, substantial gaps in our knowledge exist regarding the cell ular and functional roles, expression, and regulation of different subtypes of K V channels in DSM. Thus, further molecular, patch-clamp, and functional studies characterizing the K V channels, particularly in human DSM, are urgently needed. Future investigations in this area may lead to the development of selective pharmaco logical or genetic therapies for OAB. 4 
BK channels
The BK channel is highly expressed in DSM, 22, 24, 35 and is arguably the most important physiologically relevant K + channel that regulates DSM function. 13, 14, 17, 19, 20, 22, 24, 32, 34, 43, 44, 57, 58 This importance arises from the fact that the BK channel is the only member of the K + channel family that is activated by both voltage and
, so is uniquely suited to serve as a Ca 2+ -voltage signal integrator in the modulation of membrane excitability. 10 These channels have a single-channel conductance of 100-250 pS, hence the names 'big K + ' or 'Maxi-K' channel. BK channels are selectively blocked with high affinity by the scorpion venoms iberiotoxin and charybdo toxin 59 and the Penicillium mycotoxin paxilline. 60 Depending on the experimental conditions, DSM single BK channel conductance varies from 122 pS to 244 pS in guinea pigs, 14, 61 170-200 pS in rats and humans, 62 214 pS in mice 24 and 136 pS in humans.
22
The BK channels are highly dense in guinea pig DSM cells (~21 channels per μm 2 ). 63 The BK channel's poreforming α-subunit has the structure of the K V channel's α-subunit with the addition of an S0 transmembrane segment (providing a 7S transmembrane architecture) and a long intracellular domain (S7-S10) at the C-terminus containing the Ca 2+ sensor (Figure 1 ). In addition to the pore-forming α-subunits, the BK channels may also contain one of the four known tissuespecific regulatory subunits (BKβ1-BKβ4), with BKβ1 being smooth-muscle-specific and BKβ4 neuronspecific. Although BKβ1 is the primary auxiliary subunit in DSM, 24 recent studies at both mRNA and protein levels have also identified the presence of BKβ4 in rat, mouse and human DSM In DSM from a rat model with partial urethral obstruction (PUO), BKβ4 subunit expression decreases gradually with increasing PUO severity. 64 Under the pathological conditions of PUO, DSM exhibits increased phasic contractions as BKβ4 subunit expression decreases. 64 Pharmacological blockade of BK channels increases the amplitude and duration of spontaneous action potentials, indicating that the repolarization phase of the DSM action potential is mediated by BK channel activity. 13, 14, 65 Blocking the BK channel with iberiotoxin depolarizes the resting membrane potential in both isolated DSM cells and intact DSM tissue. 14, 22, 23 Genetic deletion of the BK α-subunit in mice causes sustained membrane depolariza tion in DSM cells. 17, 44 Collectively, these findings indicate that BK channels control the resting membrane potential in both rodent and human DSM (Figure 2) .
In DSM of humans and various other species, pharmaco logical inhibition of DSM BK channels also increases the amplitude, duration and force of the spontaneous phasic contractions, as well as DSM tone.
19 releases from the RyRs (Figure 4) . The suggestion that Ca 2+ sparks have a role in smooth muscle relaxation through local BK channel activation, causing transient BK currents (TBKCs; also known as spontaneous transient outward currents [STOCs]) (Figure 3) , was first proposed by Mark Nelson's group in 1995. 71 In guinea pig DSM, BK channels and RyRs co-localize at junctional areas of the cell membrane and SR, where Ca 2+ sparks originate to trigger TBKCs. 57, 63 In DSM cells, the Ca 2+ sparks and related TBKCs are effectively inhibited by ryanodine ( Figures 3 and 4) . A large, multidisciplinary approach, including both single-channel and whole-cell patch-clamp recordings on freshly isolated human DSM cells from 53 patients without history of OAB, has now provided the first systematic identification and characterization of the BK channel in native human DSM.
In DSM, stimulation of β-adrenergic receptors (β-ARs) increases intracellular cAMP concentration, which activates PKA that, in turn, phosphorylates specific proteins resulting in DSM relaxation (Figure 4) . 1, 5, 17, 15 Compelling evidence suggests that BK channels are activated by stimula tion of β-ARs to promote relaxation of guinea pig, rat and mouse DSM. 17 (Figure 4) . Inhibition of the BK channel with iberiotoxin in wildtype mouse DSM significantly reduces β-AR-mediated and PKA-mediated DSM relaxations in response to isoprenaline and forskolin, respectively. 17 Paradoxically, DSM from BK α-subunit knock-out mice showed enhanced sensitivity to isoprenaline and forskolin, 17 indicating that compensatory mechanisms in the β-ARcAMP-PKA signal transduction pathway might partially overcome the permanent loss of BK channels in β-ARmediated relaxation, even though the BK channel is a critical element of DSM excitability and contractility. These findings are also supported by a follow-up study in which an alternative BK α-subunit knock-out mouse model was used.
44 β-AR agonists can also modulate K + conductance in human DSM. 72 As β 3 -AR and BK channels are functionally coupled at the RyR level to mediate relaxation of rat DSM (Figure 4) , 23 alterations in this functional coupling might be involved in the pathophysiology of OAB. These findings support the concept that selective β 3 -AR agonists might be effective drugs for controlling urinary bladder function. 23 The overall physiological function of the BK channel is to reduce membrane excitability and oppose both myogenic and neurogenic human DSM contractions.
Disrupting this function would lead to increased DSM contractility and DO. Indeed, increasing evidence collected during the past decade suggests that alterations in BK channel expression, regulation or function have very important implications for normal and abnormal bladder physiology. Also, the BK channel seems to be the most likely candidate involved in DO etiology. BK channel inhibition with iberiotoxin increases DSM excitability, 14 and analogous increases in DSM excitability are caused by experimental PUO. 74 In addition, BK channel inhibition with iberiotoxin leads to increased DSM contractility, 17 patients. 33 Furthermore, BK channel activity is reduced in patients with neurogenic OAB, leading to increased DO in combination with reduced iberiotoxin-sensitive currents, as shown by combined patch-clamp and DSM contractility studies.
30 DSM cells from rats with experimental PUO also show decreased BK channel expression and reduced iberiotoxin-sensitive currents, indicating decreased BK channel activity. 75 Expression of RyR, which provides negative feedback regulation of the BK channel to control normal DSM contractility (Figure 4) , is decreased in DSM from rats with experimental PUO.
31 DSM cells of RyR2 knockout mice have decreased TBKC frequency, resulting in a depolarized membrane potential and DO. 76 Thus, changes in BK channel regulatory mechanisms, such as RyR, might be implicated in the pathogenesis of DO and OAB.
31,76 OAB prevalence is well known to increase with age, 27 and our unpublished observations indicate that BK channel expression decreases with age (G. V. Petkov, unpublished data), consistent with findings that aging reduces membrane BK channel density in coronary and corporal smooth muscle. 77, 78 Decreased BK channel expression has been reported in patients with benign prostatic hyperplasia and associated DO, as well as in rabbits with PUO-induced DO. 29 Genetic deletion of the BKβ1 or pore-forming BK α-subunits also leads to DO. 17, 24, 32, 34, 44 In rats, overexpression of the BK α-subunit using gene transfer techniques eliminated DO caused by PUO, 79 consistent with the opposite phenom enon (increased DSM contractility) observed in knock-out mice lacking BK channel subunits. 17, 24, 32, 34, 44 BK channel gene transfer is in a phase I clinical trial for treatment of erectile dysfunction, and a similar trial is planned for OAB. [80] [81] [82] [83] Thus, the BK channel represents a novel opportunity for therapeutic intervention in human DSM.
SK channels
The SK channels (also known as K Ca 2 channels) have a single-channel conductance of 5-20 pS, 10 and structurally resemble the K V channels but are voltage-insensitive. SK channels, regulated by Ca 2+ and calmodulin, 84 contribute to the DSM action potential after the hyper polarization phase. 11, 12, 25 These channels have a low density in guinea pig DSM cells (~0.01 SK channels per μm 2 or ~50 SK channels per cell). 20 The low SK channel density, along with their pronounced Ca 2+ sensitivity, uniquely suits these channels as sensors for changes in global Ca 2+ induced by activation of L-type Ca V channels during the DSM action potential. Apamin, a peptide from bee venom, blocks all of the three known SK channel subtypes (SK1-SK3 [also known as K Ca 2.1-K Ca 2.3]) with high potency (Figure 3) , and increases DSM contractility. 12, [19] [20] [21] 26, 40, 41, 66, 67, 85 In a conditional knock-out mouse model, overexpression of the SK3 channel elevated SK currents, which increased bladder capacity and decreased the frequency of DSM phasic contractions in vitro, whereas suppression of SK3 channel expression significantly increased the frequency of DSM phasic contractions in vitro and nonvoiding contractions in vivo.
21
Studies in SK2 knock-out mice suggest that SK2 channels are another essential contributor to DSM function. 85 Pharmacological activation of SK channels with specific openers might be a novel approach to restoring normal DSM function. Urodynamic studies in rats showed that NS309, a potent SK/IK channel activator, increases bladder capacity and decreases voiding frequency.
45 NS4591, another SK/IK channel activator, inhibits carbachol-induced DSM contractions in vitro 86 and bladder overactivity in vivo. 87 In 2009, Heike Wulff 's group at the University of California at Davis designed SKA-31, a new SK/IK channel opener, which is the most potent and selective activator of SK and IK channels known to date. 88 A recent study using a combined experimental approach involving single-cell RT-PCR, western blot, perforated whole-cell patch-clamp and DSM contractility recordings indicated that pharmacological activation of SK channels with SKA-31 can reduce the excitability and contractility of guinea pig DSM. 41 Moreover, the study established that SK channels, but not IK channels, mediate SKA-31 effects in DSM. 41 In essence, SK channels have fundamental roles in regulating DSM action potentials, related phasic contractions and, therefore, bladder function. However, many aspects of the regulatory mechanisms of DSM SK channels remain unknown, and knowledge about the role of SK channels in human DSM function remains limited.
25,66,89 Thus, it is necessary to obtain such informa tion directly from human DSM using the patch-clamp technique.
IK channels
IK channels (also known as SK4 or K Ca 3.1 channels) have single-channel conductance of 20-80 pS, 10 and, like SK channels, structurally resemble the K V channels but are also voltage-insensitive. IK channels have been shown to be expressed at the mRNA level in mouse DSM. 90 We have also shown mRNA expression of IK channels in native guinea pig DSM using single-cell RT-PCR, and further confirmed IK channel protein expression with western blot analysis. 41 Studies using charybdotoxin suggest that IK channels may have a functional role in mouse DSM; 13, 90 however, such claims require further evidence, as charybdotoxin inhibits both IK and BK channels. 59 The discovery of the selective IK channel inhibitor, TRAM-34, 91 enabled us to study the functional role of this channel in the DSM. Even at high concentrations (1-30 μmol/l), TRAM-34 does not affect the myogenic and neurogenic contractions of DSM strips isolated from rats, guinea pigs and humans. 40, 41 Although the IK channel is expressed at the mRNA and protein levels, patch-clamp and functional studies did not confirm a role for IK channels in guinea pig and rat DSM excitability and contractility.
40,41
Inward-rectifying ATP-sensitive K + channels The K ir channels have inward rectification properties, which refers to the fact that the inward K + current, under hyperpolarizing conditions (below the K + equilibrium potential) has a higher amplitude compared to the outward K + current elicited under equivalent depolarizing conditions. 10 In DSM, the K ir channel family is represented by the ATP-sensitive K + channels (K ATP ; also known as K ir 6 channels), which are composed of four inwardly rectifying K + channel subunits (K ir 6) and four regulatory sulphonylurea receptor subunits, and have single-channel conductance of 11-12 pS. 92, 93 K ATP channels are inhibited by intracellular ATP and by sulphonyl urea agents. They are activated when the intracellular ATP concentration is low and the ADP concentration is high, thus linking the cell's metabolic state with its membrane excitability. The specific K ATP channel inhibitor, glibenclamide, 16,94,95 does not affect DSM excitability or contractility in the absence of K ATP channel stimulation, a finding that questions whether or not K ATP channels contribute to DSM resting membrane potential under normal physiological conditions; 12, 26, 93 however, pharmaco logical activation of K ATP channels causes membrane hyperpolarization, which closes the L-type Ca V channels, thereby reducing DSM contractility. 16 Various chemically unrelated compounds, known as K ATP channel openers (such as cromakalim, levcromakalim, pinacidil, diazoxide, ZD6169, P1075 and A-312110) activate DSM K ATP channels directly, causing decreased membrane excitability and contractility. 4, 5, 12, 16, [92] [93] [94] [95] [96] [97] The concept of increasing K ATP channel opening pharmaco logically for the treatment of OAB was first proposed by Karl-Erik Andersson's group as early as 1988. 98 However, the actual discovery of the K ATP channel in guinea pig DSM using the patch-clamp technique was first achieved in 1993 by Nelson's group, 99 and, more recently, K ATP channels were also identified at a single channel level in pig and human DSM cells. 92, 93 To date, there is no clear evidence that K ATP channelopathies are involved in DO etiology. Indeed, it is doubtful that the K ATP channels are involved in bladder pathologies, as DSM strips isolated from various knock-out mouse models lacking different K ATP channel subunits show no differences in contractility when compared with DSM strips from mice with functional K ATP channels (G. V. Petkov, unpublished data). Thus, it is unlikely that mutations in K ATP channels in particular are the cause of DO and OAB. In addition, the pharma ceutical industry has failed to develop bladder-selective K ATP channel openers, owing to a lack of DSM specificity. 4 Interestingly, the density of K ATP channels is significantly higher in DSM compared to other tissues; 16,92,95 therefore, one way to achieve bladder-selective effects could be to apply lower doses of K ATP channel openers that theoretically would not affect other tissues with lower K ATP channel density. Indeed, studies have shown that K ATP channels can be significant modulators of the membrane potential in DSM, and that ~1% of the functional K ATP channels need to be activated in order to inhibit DSM action potentials and related phasic contractions.
16
Two-pore-domain channels The K 2P channels, also known as 'leak K + channels' , consist of a pair of 4S transmembrane subunits linked in a tandem dimer that forms a functional channel (Figure 1) . In addition to setting the cell's resting membrane potential (Figure 2 ), these channels facilitate many other functions, such as stretch, oxygen, pH and temperature sensing. 100 A major obstacle in studying the K 2P channels has been the lack of selective channel inhibitors. Studies by Sang-Don Koh's group at the University of Nevada have characterized the functional role of some DSM K 2P channels under normal and pathological conditions.
28,101,102 pH-sensitive K 2P channels of the TASK-1 and TASK-2 subtypes were shown to be expressed and functional in mouse DSM. 102 These channels have an important role in stabilizing the DSM cell's resting membrane potential. 102 DSM relaxes during the bladder filling phase to accommodate high bladder capacity while maintaining low intravesical pressure. 1 However, the mechanisms responsible for the stabilization of bladder excitability during stretch have been subject to debate. Mouse DSM expresses functional K 2P , stretch-dependent K + channels of the TREK-1 subtype 101 that have also been identified in cultured human DSM cells, which show 12-fold higher expression levels compared to cultured aortic myocites. 103 BL-1249, a putative TREK-1 channel opener, produces a concentration-dependent membrane hyperpolarization in cultured human DSM cells, inhibits the KCl-induced contractions of rat DSM isolated strips, and decreases the frequency of isovolumic contractions in vivo, without significantly affecting blood pressure in rats. 103 These channels may, therefore, have a physiological role in suppressing DSM excitability and contractility in response to stretch during bladder filling. TREK-1 channels are implicated in some bladder pathologies. Systemic administra tion of l-methioninol, a TREK-1 channel inhibitor, induces nonvoiding contractions during bladder filling.
28 In a mouse model of PUO, the DSM TREK-1 channel is downregulated, leading to DO. 28 In the future, K 2P channels might become important therapeutic targets in bladder dysfunction.
Conclusions

K
+ channels control DSM cell excitability by maintaining the resting membrane potential and shaping the action potentials that trigger DSM phasic contractions. Altering DSM K + channel properties can, therefore, have profound effects on urinary bladder function. Among all K + channels, the BK, SK and K V channels are the most important physiological regulators of DSM excitability and contractility. As the K V channel family is represented by 40 genes, forming different K V channel homomultimers or heteromultimers, many new K V channel subtypes with unique roles in DSM function are likely to be discovered. Moreover, such DSM-specific K V channels will represent tissue-selective drug targets.
Evidence collected during the past decade suggests that BK channel dysfunction leads to some forms of DO. A clinical trial is currently underway to examine the effects of infusing a BK channel plasmid as a treatment for OAB, further underscoring the potential utility of BK channel manipulation. Increasing BK channel expression levels can reduce DO; alternatively, targeting the BK, SK or K V channels with synthetic channel-opening agents represents a novel opportunity for pharmacological manipulation of the bladder to reduce DO. Genetic manipulation of K + channels or the use of channel openers could, in the future, replace the commonly prescribed therapy for OAB-antimuscarinic agents, which currently have limited effectiveness and numerous adverse effects. To facilitate these novel therapeutic approaches, however, we first need to better understand K + channel functions and regulatory mechanisms in human DSM. Thus, it is necessary for us to obtain further evidence regarding the role of K + channels in DSM function directly from native human DSM cells in health and disease using a multidisciplinary approach, including the patch-clamp technique, and correlate the electrophysiological findings with patients' clinical profiles.
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